The Magazine of Corporate Responsibility

Compliance & Governance rss

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers(0)

October 12, 2017

Decisions in recent legal cases are fueling debate about whether the First Amendment’s protection of commercial speech could undermine the FDA’s ability to prevent drug marketing abuses. Some worry that changing political dynamics – especially the anti-regulatory aims of the Trump administration and Republican-dominated Congress – could free drug makers to push the boundaries of the law.

Full Story»

The Conflict Between a Corporation’s Global Standards and National Law

China’s extensive state censorship is just one example of the challenges that companies frequently confront when doing business globally. In an excerpt from his new book, former GE legal counsel Ben W. Heineman, Jr. examines the “recurrent dilemma” confronting businesses when a corporation’s global ethical standards collide with national law.

For Big Railroads, a Carload of Whistleblower Complaints

Big railroads are often targeted by complaints of illegal retaliation against whistleblowers who disclose safety hazards or report on-the-job injuries. A recent $1.25 million damage award to a former BNSF Railway Co. employee spotlights what critics say is the unjust punishment sometimes meted out to railroad workers who report injuries or safety problems.

‘I Swear I Will Be Ethical’: Why an Oath is Just a Start

Some 90,000 bankers in the Netherlands are now required to take an oath pledging integrity, an effort to help restore confidence in the financial industry. Other proposals are being considered in countries and industries where employees are being asked to publicly reaffirm their commitment to a code of conduct. Columnist Gael O’Brien says such oaths are fine but not enough; what’s needed is strong, consistent corporate leadership that shapes enduring ethical cultures.


More in this category